Skip to main content
Erschienen in: Cardiovascular Intervention and Therapeutics 1/2016

01.01.2016 | Original Article

Characterization of real-world patients with low fractional flow reserve immediately after drug-eluting stents implantation

verfasst von: Yo Kimura, Nobuhiro Tanaka, Hiroyuki Okura, Kiyoshi Yoshida, Masafumi Akabane, Tadateru Takayama, Atsushi Hirayama, Tomohisa Tada, Takeshi Kimura, Hitoshi Takano, Kyoichi Mizuno, Takumi Inami, Hideaki Yoshino, Akira Yamashina

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) for coronary artery disease has been validated. The present study aimed to identify the variables that influence FFR immediately after drug-eluting stents (DESs) implantation. We retrospectively analyzed 167 patients, who had been implanted with DESs at 6 Japanese institutions and had obtained the FFR values before and immediately after PCI. Intravascular ultrasound (IVUS) was used to build a PCI strategy and to decide the completion of the PCI procedure in all case. Patients were categorized into the following 2 groups according to FFR after PCI: the low FFR (≤0.80) group and the high FFR (>0.80) group. Despite successful PCI evaluated by coronary angiography and IVUS, 18.6 % of real-world patients were in the low FFR group. The proportion of the left anterior descending artery (LAD) was significantly greater in the low FFR group than in the high FFR group (87.1 vs 56.6 %; P < 0.01). Multivariate logistic regression analysis revealed that the LAD-to-non-LAD odds ratio for a low FFR (≤0.80) was 7.34 (95 % CI 1.63–32.95; P < 0.01) after adjustment for FFR value before PCI, suggesting that it is difficult to improve the hemodynamics of the LAD lesions even after successful PCI. The LAD was the strongest contributor to the inadequate recovery of FFR immediately after PCI, thus eliciting heed when treating the LAD lesions.
Literatur
1.
Zurück zum Zitat Bech GJ, De Bruyne B, Pijls NH, de Muick ED, Horne JC, Escaped J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928–34.PubMedCrossRef Bech GJ, De Bruyne B, Pijls NH, de Muick ED, Horne JC, Escaped J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928–34.PubMedCrossRef
2.
Zurück zum Zitat Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, vant Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol. 2007;49:2105–11.PubMedCrossRef Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, vant Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol. 2007;49:2105–11.PubMedCrossRef
3.
Zurück zum Zitat Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, et al.; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360:213–224. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, et al.; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360:213–224.
4.
Zurück zum Zitat Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al.; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease. 2-year follow-up of the FAME study. J Am Coll Cardiol 2010; 56:177–84. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al.; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease. 2-year follow-up of the FAME study. J Am Coll Cardiol 2010; 56:177–84.
5.
Zurück zum Zitat De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, FAME 2 Trial Investigators, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;67:991–1001.CrossRef De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, FAME 2 Trial Investigators, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;67:991–1001.CrossRef
6.
Zurück zum Zitat Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Fractional Flow Reserve (FFR) Post-Stent Registry Investigators, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002;105:2950–4.PubMedCrossRef Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Fractional Flow Reserve (FFR) Post-Stent Registry Investigators, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002;105:2950–4.PubMedCrossRef
7.
Zurück zum Zitat Ishii H, Kataoka T, Kobayashi Y, Tsumori T, Takeshita H, Matsumoto R, et al. Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation. Heart Vessel. 2011;26:572–81.CrossRef Ishii H, Kataoka T, Kobayashi Y, Tsumori T, Takeshita H, Matsumoto R, et al. Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation. Heart Vessel. 2011;26:572–81.CrossRef
8.
Zurück zum Zitat Nam CW, Hur SH, Cho YK, Park HS, Yoon HJ, Kim H, et al. Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol. 2011;107:1763–7.PubMedCrossRef Nam CW, Hur SH, Cho YK, Park HS, Yoon HJ, Kim H, et al. Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol. 2011;107:1763–7.PubMedCrossRef
9.
Zurück zum Zitat Pijls NH. Fractional flow reserve to guide coronary revascularization. Circ J. 2013;77:561–9.PubMedCrossRef Pijls NH. Fractional flow reserve to guide coronary revascularization. Circ J. 2013;77:561–9.PubMedCrossRef
10.
Zurück zum Zitat Shiono Y, Kubo T, Tanaka A, Ino Y, Yamaguchi T, Tanimoto T, et al. Long-Term Outcome After Deferral of Revascularization in Patients With Intermediate Coronary Stenosis and Gray-Zone Fractional Flow Reserve. Circ J. 2015;79:91–5.PubMedCrossRef Shiono Y, Kubo T, Tanaka A, Ino Y, Yamaguchi T, Tanimoto T, et al. Long-Term Outcome After Deferral of Revascularization in Patients With Intermediate Coronary Stenosis and Gray-Zone Fractional Flow Reserve. Circ J. 2015;79:91–5.PubMedCrossRef
11.
Zurück zum Zitat TIMI Study Group. The thrombolysis in myocardial infarction trial. Phase I findings. N Engl J Med. 1985;312:932–6.CrossRef TIMI Study Group. The thrombolysis in myocardial infarction trial. Phase I findings. N Engl J Med. 1985;312:932–6.CrossRef
12.
Zurück zum Zitat Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Multivessel Angioplasty Prognosis Study Group, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Circulation. 1990;82:1193–202.PubMedCrossRef Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Multivessel Angioplasty Prognosis Study Group, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Circulation. 1990;82:1193–202.PubMedCrossRef
13.
Zurück zum Zitat Ambrose JA, Winters SL, Stern A, Eng A, Teichholz LE, Gorlin R, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol. 1985;5:609–16.PubMedCrossRef Ambrose JA, Winters SL, Stern A, Eng A, Teichholz LE, Gorlin R, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol. 1985;5:609–16.PubMedCrossRef
14.
Zurück zum Zitat Hanekamp CE, Koolen JJ, Pijls NH, Michels HR, Bonnier HJ. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 1999;99:1015–21.PubMedCrossRef Hanekamp CE, Koolen JJ, Pijls NH, Michels HR, Bonnier HJ. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 1999;99:1015–21.PubMedCrossRef
15.
Zurück zum Zitat Amaya K, Takazawa K, Tanaka N, Takeda K, Matsuoka O, Kurosu F, et al. Coronary artery dissection following angioplasty evaluated by fractional flow reserve: report of three cases. J Cardiol. 2001;38:337–42.PubMed Amaya K, Takazawa K, Tanaka N, Takeda K, Matsuoka O, Kurosu F, et al. Coronary artery dissection following angioplasty evaluated by fractional flow reserve: report of three cases. J Cardiol. 2001;38:337–42.PubMed
16.
Zurück zum Zitat Ito T, Tani T, Fujita H, Ohte N. Relationship between fractional flow reserve and residual plaque volume and clinical outcomes after optimal drug-eluting stent implantation: insight from intravascular ultrasound volumetric analysis. Int J Cardiol. 2014;176:399–404.PubMedCrossRef Ito T, Tani T, Fujita H, Ohte N. Relationship between fractional flow reserve and residual plaque volume and clinical outcomes after optimal drug-eluting stent implantation: insight from intravascular ultrasound volumetric analysis. Int J Cardiol. 2014;176:399–404.PubMedCrossRef
17.
Zurück zum Zitat Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, et al. Selection of surgical of percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surge. 2006;82:1420–9.CrossRef Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, et al. Selection of surgical of percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surge. 2006;82:1420–9.CrossRef
18.
Zurück zum Zitat Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the coronary artery bypass graft surgery trialists collaboration. Lancet. 1994;344:563–70.PubMedCrossRef Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the coronary artery bypass graft surgery trialists collaboration. Lancet. 1994;344:563–70.PubMedCrossRef
19.
Zurück zum Zitat Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization, Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery(EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010;31:2501–55.PubMedCrossRef Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization, Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery(EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010;31:2501–55.PubMedCrossRef
20.
Zurück zum Zitat Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 60:e44–e164. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 60:e44–e164.
21.
Zurück zum Zitat Glineur D, Noirhomme P, Reisch J, El Khoury G, Astarci P, Hanet C. Resistance to flow of arterial Y-grafts 6 months after coronary artery bypass surgery. Circulation. 2005;112:I281.PubMed Glineur D, Noirhomme P, Reisch J, El Khoury G, Astarci P, Hanet C. Resistance to flow of arterial Y-grafts 6 months after coronary artery bypass surgery. Circulation. 2005;112:I281.PubMed
22.
Zurück zum Zitat Glineur D, Boodhwani M, Poncelet A, De Kerchove L, Etienne PY, Noirhomme P, et al. Comparison of fractional flow reserve of composite Y-grafts with saphenous vein or right internal thoracic arteries. J Thorac Cardiovasc Surg. 2010;140:639–45.PubMedCrossRef Glineur D, Boodhwani M, Poncelet A, De Kerchove L, Etienne PY, Noirhomme P, et al. Comparison of fractional flow reserve of composite Y-grafts with saphenous vein or right internal thoracic arteries. J Thorac Cardiovasc Surg. 2010;140:639–45.PubMedCrossRef
Metadaten
Titel
Characterization of real-world patients with low fractional flow reserve immediately after drug-eluting stents implantation
verfasst von
Yo Kimura
Nobuhiro Tanaka
Hiroyuki Okura
Kiyoshi Yoshida
Masafumi Akabane
Tadateru Takayama
Atsushi Hirayama
Tomohisa Tada
Takeshi Kimura
Hitoshi Takano
Kyoichi Mizuno
Takumi Inami
Hideaki Yoshino
Akira Yamashina
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
Cardiovascular Intervention and Therapeutics / Ausgabe 1/2016
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-015-0342-4

Weitere Artikel der Ausgabe 1/2016

Cardiovascular Intervention and Therapeutics 1/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.